Saturday, December 2, 2023
Clinical Advances in
Low back pain and osteoarthritis are two of the most common pain conditions encountered by clinicians. Chronic pain is often mismanaged and its treatment remains complex. The opioid crisis has increased the need to identify novel and established agents to reduce opioid dosing or the overall need for opioid analgesics. This initiative aims to educate clinicians on recognizing and diagnosing the various clinical presentations of chronic pain, individualizing treatment plans, as well as learn about the latest clinical data on novel analgesic targets.
This program is supported by an independent education grant funded by
Pfizer Inc., in partnership with Lilly USA, LLC.
Developed through a partnership between Medscape, American Academy of Pain Medicine, New Jersey Academy of Family Physicians, and University of California, San Diego School of Medicine.
Steering Committee Chair
Professor of Clinical Anesthesiology
Chair
Division of Pain Medicine
University of California, San Diego
La Jolla, California
Associate Professor of Anesthesiology and Pain Medicine
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas
Director
Aiken Professional Association
Aiken Regional Medical Center
Aiken, South Carolina
Distinguished Professor
University of California at Davis School of Medicine
Sacramento, California
Faculty Associate
Family Medicine Residency
Reading Hospital of Tower Health
Reading, Pennsylvania
Associate Professor of Anesthesiology
Chief, Pain Medicine
Northwestern University
Feinberg School of Medicine
Chicago, Illinois
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Heron Therapeutics; INSYS Therapeutics; Jazz Pharmaceuticals, Inc.; Pfizer Inc.; Sorrento Therapeutics
Has disclosed no relevant financial relationships.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Pfizer Inc.
Served as a speaker or a member of a speakers bureau for: Pfizer Inc.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen Inc.
Served as a speaker or a member of a speakers bureau for: Radius Health
Received grants for clinical research from: Pfizer Inc.
Has disclosed no relevant financial relationships.
Has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Halyard Health
Owns stock, stock options, or bonds from: Nevro